Please wait while we load the requested 20-F report or click the link below:
https://last10k.com/sec-filings/report/1651625/000095010318003508/dp88149_20f.htm
January 2023
November 2022
October 2022
September 2022
August 2022
July 2022
June 2022
June 2022
May 2022
April 2022
Please wait while we load the requested 20-F report or click the link below:
https://last10k.com/sec-filings/report/1651625/000095010318003508/dp88149_20f.htm
Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Ac Immune Sa.
Ac Immune Sa's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 20-F Annual Report
Material Contracts, Statements, Certifications & more
Ac Immune Sa provided additional information to their SEC Filing as exhibits
Ticker: ACIU
CIK: 1651625
Form Type: 20-F Annual Report
Accession Number: 0000950103-18-003508
Submitted to the SEC: Tue Mar 20 2018 6:03:27 AM EST
Accepted by the SEC: Tue Mar 20 2018
Period: Sunday, December 31, 2017
Industry: Pharmaceutical Preparations